At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
caffeinated and decaffeinated coffeeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute Effects of Caffeinated and Decaffeinated Coffee Consumption on Energy Intake, Appetite, Inflammation and Glucose Metabolism
In Brief
A clinical study evaluating caffeinated and decaffeinated coffee for Health. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The purpose of the study is to investigate whether caffeinated and decaffeinated coffee consumption has acute effects on subjective appetite feelings, energy intake and biochemical markers related to appetite, inflammation and glucose metabolism compared to water consumption.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealth
CountriesGreece
CollaboratorsBeth Israel Deaconess Medical Center
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
Primary CompletionMay 2009
First PostedAug 2010
TodayJul 2026
First PostedAug 3, 2010
Enrollment StartFeb 1, 2009
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.9 years ago
Interventions
caffeinated and decaffeinated coffeeother
3 treatments on separate days, i.e. a standard breakfast with oral ingestion of 200 ml of either caffeinated coffee (3mg caffeine/kg body weight), decaffeinated coffee or water